Transforming growth factor-β (TGFβ) receptors I/II differentially regulate TGFβ1 and IGF-binding protein-3 mitogenic effects in the human placenta

Endocrinology

Volumn 151, Issue 4, 2010, Pages 1723-1731

  Forbes, Karen ^a   Souquet, Benoit ^a   Garside, Rebecca ^a   Aplin, John D ^a   Westwood, Melissa ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CONNECTIVE TISSUE GROWTH FACTOR; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMAD PROTEIN; SMAD2 PROTEIN; SMALL INTERFERING RNA; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTROPHOBLAST; ENZYME ACTIVATION; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOGENESIS; NUCLEOTIDE SEQUENCE; PLACENTA; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYNCYTIOTROPHOBLAST;

ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; PLACENTA; PREGNANCY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77950256025     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0896     Document Type: Article

References (56)

1. Kingdom J, Huppertz B, Seaward G, Kaufmann P 2000 Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 92:35-43
2. Sibley CP, Turner MA, Cetin I, Ayuk P, Boyd CA, D'Souza SW, Glazier JD, Greenwood SL, Jansson T, Powell T 2005 Placental phenotypes of intrauterine growth. Pediatr Res 58:827-832
3. Han VK, Bassett N, Walton J, Challis JR 1996 The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab 81:2680-2693
4. Forbes K, Westwood M 2008 The IGF axis and placental function: a mini review. Horm Res 69:129-137
5. Forbes K, Westwood M, Baker PN, Aplin JD 2008 Insulin-like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta. Am J Physiol Cell Physiol 294:C1313-C1322
6. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A 2001 The somatomedin hypothesis: 2001. Endocr Rev 22:53-74
7. Klauwer D, BlumWF,Hanitsch S, RascherW, Lee PD, KiessW 1997 IGF-I, IGF-II, free IGF-I and IGFBP-1, -2 and -3 levels in venous cord blood: relationship to birthweight, length and gestational age in healthy newborns. Acta Paediatr 86:826-833
8. Watson CS, Bialek P, Anzo M, Khosravi J, Yee SP, Han VK 2006 Elevated circulating insulin-like growth factor binding protein-1 is sufficient to cause fetal growth restriction. Endocrinology147:1175-1186
9. Osorio M, Torres J, Moya F, Pezzullo J, Salafia C, Baxter R, Schwander J, Fant M 1996 Insulin-like growth factors (IGFs) and IGF binding proteins-1, -2, and -3 in newborn serum: relationships to fetoplacental growth at term. Early Hum Dev 46:15-26
10. Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, Hintz RL, Rosenfeld RG 1995 Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 80:1548-1555
11. Modric T, Silha JV, Shi Z, Gui Y, Suwanichkul A, Durham SK, Powell DR, Murphy LJ 2001 Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. Endocrinology 142:1958-1967
12. Rogers J, Wiltrout L, Nanu L, Fant ME 1996 Developmentally regulated expression of IGF binding protein-3 (IGFBP-3) in human placental fibroblasts: effect of exogenous IGFBP-3 on IGF-1 action. Regul Pept 61:189-195
13. Firth SM,Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854
14. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P 1995 The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361-367
15. Silha JV, Sheppard PC, Mishra S, Gui Y, Schwartz J, Dodd JG, Murphy LJ 2006 Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms. Endocrinology 147:2112-2121
16. Bach LA, Headey SJ, Norton RS 2005 IGF-binding proteins: the pieces are falling into place. Trends Endocrinol Metab 16:228-234
17. Weinzimer SA, Gibson TB, Collett-Solberg PF, Khare A, Liu B, Cohen P 2001 Transferrin is an insulin-like growth factor-binding protein-3 binding protein. J Clin Endocrinol Metab 86:1806-1813
18. Lee KW, Liu B, Ma L, Li H, Bang P, Koeffler HP, Cohen P 2004 Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem 279:469-476
19. Huang SS, Huang JS 2005 TGF-βcontrol of cell proliferation. J Cell Biochem 96:447-462
20. Huang SS, Ling TY, Tseng WF, Huang YH, Tang FM, Leal SM, Huang JS 2003 Cellular growth inhibition by IGFBP-3 and TGF-β1 requires LRP-1. FASEB J 17:2068-2081
21. Kuemmerle JF, Murthy KS, Bowers JG 2004 IGFBP-3 activates TGF-β receptors and directly inhibits growth in human intestinal smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 287: G795-G802
22. Jones RL, Stoikos C, Findlay JK, Salamonsen LA 2006 TGF-β superfamily expression and actions in the endometrium and placenta. Reproduction 132:217-232
23. Morrish DW, Dakour J, Li H 1998 Functional regulation of human trophoblast differentiation. J Reprod Immunol 39:179-195
24. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ 1999 Inhibition of TGF-β3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 103:1641-1650
25. Xu G, Guimond MJ, Chakraborty C, Lala PK 2002 Control of proliferation, migration, and invasiveness of human extravillous trophoblast by decorin, a decidual product. Biol Reprod 67:681-689
26. Xuan YH, Choi YL, Shin YK, Ahn GH, Kim KH, Kim WJ, Lee HC, Kim SH 2007 Expression of TGF-β signaling proteins in normal placenta and gestational trophoblastic disease. Histol Histopathol 22:227-234
27. Forbes K, Desforges M, Garside R, Aplin JD, Westwood M 2009 Methods for siRNA-mediated reduction of mRNA and protein expression in human placental explants, isolated primary cells and cell lines. Placenta 30:124-129
28. Matthews LC, Taggart MJ, Westwood M 2005 Effect of cholesterol depletion on mitogenesis and survival: the role of caveolar and noncaveolar domains in insulin-like growth factor-mediated cellular function. Endocrinology 146:5463-5473
29. Conover CA 1991 Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3. Endocrinology 129:3259-3268
30. Nakao A, Röijer E, Imamura T, Souchelnytskyi S, Stenman G, Heldin CH, ten Dijke P 1997 Identification of Smad2, a human Mad-related protein in the transforming growth factor β signaling pathway. J Biol Chem 272:2896-2900
31. Cabello-Verrugio C, Brandan E 2007 A novel modulatory mechanism of transforming growth factor-β signaling through decorin and LRP-1. J Biol Chem 282:18842-18850
32. Zhang H, Lee JM,WangY, Dong L,KoKW,Pelletier L, YaoZ2008 Mutational analysis of the FXNPXY motif within LDL receptor-related protein 1 (LRP1) reveals the functional importance of the tyrosine residues in cell growth regulation and signal transduction. Biochem J 409:53-64
33. Ceschin DG, SánchezMC,ChiabrandoGA2009 Insulin induces the low density lipoprotein receptor-related protein 1 (LRP1) degradation by the proteasomal system in J774 macrophage-derived cells. J Cell Biochem 106:372-380
34. Grey A, Zhu Q, Watson M, Callon K, Cornish J 2006 Lactoferrin potently inhibits osteoblast apoptosis, via an LRP1-independent pathway. Mol Cell Endocrinol 251:96-102
35. Yang M, Huang H, Li J, Li D, Wang H 2004 Tyrosine phosphorylation of the LDL receptor-related protein (LRP) and activation of the ERK pathway are required for connective tissue growth factor to potentiate myofibroblast differentiation. FASEB J 1:920-921
36. Wang HS, Chard T 1992 Chromatographic characterization of insulin-like growth factor-binding proteins in human pregnancy serum. J Endocrinol 133:149-159
37. Han VK, Carter AM 2000 Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta 21:289-305
38. Sakai K, Iwashita M, Takeda Y 1997 Profiles of insulin-like growth factor binding proteins and the protease activity in the maternal circulation and its local regulation between placenta and decidua. Endocr J 44:409-417
39. Irwin JC, Suen LF, Cheng BH, Martin R, Cannon P, Deal CL, Giudice LC 2000 Human placental trophoblasts secrete a disintegrin metalloproteinase very similar to the insulin-like growth factor binding protein-3 protease in human pregnancy serum. Endocrinology 141:666-674
40. Coppock HA, White A, Aplin JD, Westwood M 2004 Matrix metalloprotease-3 and -9 proteolyze insulin-like growth factor-binding protein-1. Biol Reprod 71:438-443
41. Westwood M, Aplin JD, Collinge IA, Gill A, White A, Gibson JM 2001 α2-Macroglobulin: a new component in the insulin-like growth factor/insulin-like growth factor binding protein-1 axis. J Biol Chem 276:41668-41674
42. Leal SM, Liu Q, Huang SS, Huang JS 1997 The type V transforming growth factor βreceptor is the putative insulin-like growth factor-binding protein 3 receptor. J Biol Chem 272:20572-20576
43. Ingman WV, Robertson SA 2009 The essential roles of TGFB1 in reproduction. Cytokine Growth Factor Rev 20:233-239
44. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ 1995 Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development 121: 1845-1854
45. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB 1994 Maternal rescue of transforming growth factor-β1 null mice. Science 264:1936-1938
46. Karmakar S, Das C 2002 Regulation of trophoblast invasion by IL-1beta and TGF-β1. Am J Reprod Immunol 48:210-219
47. Tse WK, Whitley GS, Cartwright JE 2002 Transforming growth factor-β1 regulates hepatocyte growth factor-induced trophoblast motility and invasion. Placenta 23:699-705
48. Irving JA, Lala PK 1995 Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-β, IGF-II, and IGFBP-1. Exp Cell Res 217:419-427
49. Leal SM, Huang SS, Huang JS 1999 Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-β receptor in mink lung epithelial cells. J Biol Chem 274:6711-6717
50. Fanayan S, Firth SM, Butt AJ, Baxter RC 2000 Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-β (TGF-β) and the type II TGF-β receptor. J Biol Chem 275:39146-39151
51. Fanayan S, Firth SM, Baxter RC 2002 Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-β1 signaling. J Biol Chem 277:7255-7261
52. Suzuki K, Wilkes MC, Garamszegi N, Edens M, Leof EB 2007 Transforming growth factor β signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses. Cancer Res 67: 3673-3682
53. Watanabe H, de Caestecker MP, Yamada Y 2001 Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 276:14466-14473
54. Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I 2005 Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem 95:918-931
55. Hayashida T, Decaestecker M, Schnaper HW 2003 Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-β-dependent responses in human mesangial cells. FASEB J 17: 1576-1578
56. Bukowski R, Smith GC, Malone FD, Ball RH, Nyberg DA, Comstock CH, Hankins GD, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-TritschIE,CarrSR, WolfeHM,D'AltonME2007Fetalgrowth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study. BMJ 334:836